Table 2. Hazard Ratios for Index Hospitalization Comparing Mild Cognitive Impairment (MCI) Status to Normals at Baseline.
Model | HR | 95% CI | P |
---|---|---|---|
Unadjusted | 1.25 | 1.09 – 1.42 | <0.01 |
+ demographics, clinic site, Ginkgo biloba assignment | 1.22 | 1.07 – 1.40 | <0.01 |
Above + comorbidities | 1.19 | 1.04 – 1.37 | 0.01 |
Above + number of prescription medications | 1.18 | 1.03 – 1.35 | 0.02 |
Above + plus living with proxy | 1.17 | 1.02 – 1.34 | 0.02 |
Above, in participants living with proxy* | 1.39 | 1.17 – 1.66 | n/a |
Above, in participants not living with proxy* | 0.94 | 0.76 – 1.16 | n/a |
Legend: Demographics include age, sex, race, level of education. Comorbidities: hypertension, diabetes, cancer, congestive heart failure, myocardial infarction, angina, kidney disease, liver disease, stroke, emphysema. "Living with proxy" refers to whether a participant lives with the listed proxy.
The interaction of MCI at baseline and living with proxy was significant (chi-square 8.274, p=0.004), therefore the final model is presented stratified by whether the participant lives with proxy.